Gabriele MaterazziDr. Materazzi graduated from the Faculty of Medicine in Pisa and from the postgraduate school of General Surgery in Pisa. He had also postgraduate training in endocrine surgery at the Hammersmith Hospital in London (UK) and at Brown University (Rhode Island Hospital) in Providence (US). His principal research interests have been in surgical disorders of the thyroid, parathyroid, and adrenal glands. He has a particular interest in endocrine surgical oncology (thyroid and parathyroid cancer), novel technologies in endocrine surgery (Robotic Surgery, transaxillary thyroidectomy), as well as minimally invasive endocrine surgery.
Gregory RandolphGregory W. Randolph, MD, FACS, FACE, é Professor de Otorrinolaringologia e titular da Cátedra Claire e John Bertucci em Oncologia Cirúrgica da Tireoide na Escola Médica de Harvard, além de cirurgião no Massachusetts Eye & Ear Infirmary. Atua como Diretor da Divisão de Otorrinolaringologia Geral e fundou e dirige a Divisão de Cirurgia da Tireoide e Paratireoide. Atualmente, ele atua como presidente do Comitê de Cirurgia Endócrina da Associação Americana de Endocrinologia Clínica, é presidente eleito da Seção de Cirurgia Endócrina da Sociedade Americana de Cabeça e Pescoço e faz parte do Conselho de Administração do Grupo Internacional de Oncologia da Tireoide.
Laura Boucai Laura Boucai is an Associate Member at Memorial Sloan Kettering Cancer Center and an Associate Professor of Clinical Medicine at Weill Cornell Medical College. Her research interests have focused on thyroid cancer biology. She studies the genomic and transcriptomic landscape of thyroid cancer, the role of redifferentiation agents, and the impact of clonal hematopoiesis in thyroid cancer to attempt to find new therapeutic strategies for the most advanced forms of the disease. Dr. Boucai is an active member of the Endocrine Society, where she serves on the Annual Meeting Steering Committee. She is also Secretary and serves on the board of directors and executive committee of the International Thyroid Oncology Group (ITOG). Within the ATA, she is the current chair of Women in Thyroid (WIT). Dr. Boucai is a strong advocate for women and national and international trainees interested in thyroidology. Her bicultural background and strong commitment to education enable her to bridge knowledge gaps locally and in developing countries, advancing the care of patients with thyroid disease.
Michael TuttleDr. R. Michael Tuttle, endocrinologista e professor de medicina no Memorial Sloan Kettering Cancer Center, em Nova York. Sua pesquisa continua focada em aspectos importantes do manejo do câncer de tireoide, incluindo esforços para melhor definir o risco de recorrência, o risco de morte e o potencial papel da observação em cânceres de tireoide de baixo risco. Sua prática clínica é inteiramente dedicada a pacientes com câncer de tireoide, com ênfase particular em casos com doença agressiva e problemas complexos de manejo.
Michel W YehMichael Yeh é fundador e diretor do Programa de Cirurgia Endócrina e professor assistente da UCLA (Universidade de California - Los Angeles). Após cursar a Universidade Stanford e a Faculdade de Medicina de Harvard, o Dr. Yeh se especializou em cirurgia geral na Universidade da Califórnia em São Francisco. Em seguida, concluiu a prestigiosa bolsa internacional T.S. Reeve em cirurgia endócrina no Royal North Shore Hospital, em Sydney, Austrália. O Dr. Yeh é especialista em cirurgia minimamente invasiva de paratireoide e câncer de tireoide. Publicou mais de 100 artigos acadêmicos e capítulos de livros sobre esses temas. Em 2015, o Dr. Yeh fundou o Centro Endócrino multidisciplinar na UCLA, criando uma linha de serviço integrada para fornecer atendimento abrangente a pacientes com todo o espectro de tumores endócrinos, incluindo cânceres endócrinos recorrentes e metastáticos.
Seza Gulec Dr. Seza Gulec is the founding president and Chief Executive Officer of the Miami Cancer Research Center. Dr. Gulec is also the founding Chief of Surgical Oncology and Endocrinology and Director of Surgical Research at Florida International University. He is the Chief of Surgical Oncology at HCA Florida Aventura Hospital. He is a Fellow of the American College of Surgeons and a Fellow of the American College of Nuclear Medicine. He is also a member of the Society of Surgical Oncology, the American Thyroid Association, and the Society of Nuclear Medicine and Molecular Imaging. Dr. Gulec's areas of clinical expertise include treatment of thyroid and parathyroid diseases, carcinoid and neuroendocrine tumors, melanoma, breast cancer, primary and metastatic liver cancers, and pancreatic cancer. Dr. Gulec is a renowned researcher in the fields of surgical and nuclear oncology. The primary focus of his research is molecular imaging and targeted radionuclide therapy in solid tumors. His laboratory is actively involved in the development of novel positron Emission tomography (PET) imaging agents, as well as radioimmuno, radiopeptide, and radiomicrosphere therapy strategies, which include molecular theranostics and dosimetry.
